Omicron cases outside South Africa no deadlier, Australian official says
2nd Dec 2021 08:40
(Sharecast News) - On current evidence, the Omicron variant of Covid-19 did not yet appear to be any deadlier than previous ones, Australian health officials said.
Read moreAll confirmed Omicron cases in EU thus far are asymptomatic or have shown mild symptoms
30th Nov 2021 21:49
(Sharecast News) - All confirmed cases of the Omicron variant of concern detected thus far in the European Union had thus far had been either asymptomatic or shown "mild" symptoms, the bloc's pandemic watchdog said.
Read moreAstraZeneca Lynparza supplemental application gets US priority review
30th Nov 2021 07:31
(Sharecast News) - AstraZeneca said that its Lynparza breast cancer drug's supplemental new application had been accepted and granted Priority Review by the US Food and Drug Administration.
Read moreOmicron likely to fall 'some way short' of apocalyptic reboot of pandemic, Pantheon Macro says
28th Nov 2021 22:24
(Sharecast News) - Analysts at Pantheon Macroeconomics believed the most likely outcome from the appearance of the new SARS-CoV-2 variant, Omicron, would be "some way short of an apocalyptic reboot of the pandemic."
Read moreNew Covid variant triggers alarm bells around the world
26th Nov 2021 16:09
(Sharecast News) - Authorities in the UK and many other European countries moved quickly to cut travel links with South Africa and several other countries in southern Africa following the detection of a new variant of Covid-19 with a large number of mutations on the so-called 'spike' protein.
Read moreNew UK Covid variant may be less likely to cause symptoms, study shows
18th Nov 2021 14:52
(Sharecast News) - The fast-spreading variant of Covid-19 recently detected in the UK may be less likely to cause symptoms, the results of new research showed.
Read moreAstraZeneca antibody found to reduce risk of severe Covid-19 by over 80pc
18th Nov 2021 07:40
(Sharecast News) - AstraZeneca reported positive findings from recent studies into its Covid-19 antibody treatment on Thursday, reporting that when given to at-risk and immunocompromised patients before exposure to the coronavirus, it reduced the risk of developing severe disease by 83%.
Read moreAstraZeneca holds guidance as Covid vaccine turns profitable
12th Nov 2021 07:03
(Sharecast News) - AstraZeneca on Friday reported $1.05bn in third-quarter Covid vaccine sales as the not-for-profit drug added 1% to earnings in the period, while the company reiterated annual forecasts for 2021.
Read moreFriday preview: US consumer confidence, AstraZeneca in focus
11th Nov 2021 14:15
(Sharecast News) - Financial markets' focus at the end of the week will shift back towards the US.
Read moreAstraZeneca offloads rights to Eklira and Duaklir
1st Nov 2021 07:40
(Sharecast News) - AstraZeneca has agreed to transfer its global rights to 'Eklira', or aclidinium bromide, and 'Duaklir', or aclidinium bromide with formoterol, to Covis Pharma Group, it announced on Monday.
Read moreJ.P.Morgan keeps AstraZeneca as 'top pick' on growth outlook, undervaluation
21st Oct 2021 11:21
(Sharecast News) - AstraZeneca's growth outlook is the best in its sector and was not yet reflected in its share price, analysts at JP Morgan said following a 'deep dive' into the drug maker's financials.
Read moreNovavax shares plummet on report of further delays in Covid-19 vaccine
20th Oct 2021 11:10
(Sharecast News) - Novavax's manufacturing problems may be more serious than previously thought and could hamper global efforts to fight Covid-19.
Read moreValneva vaccine 'outperforms' AstraZeneca shot in trial
18th Oct 2021 10:55
(Sharecast News) - A Covid-19 vaccine being developed by Valneva performed better than AstraZeneca's jab in trials, the French biotech announced on Monday, sending its shares soaring.
Read moreAstraZeneca tells investors to reject TRC Capital 'mini-tender' offer
18th Oct 2021 07:29
(Sharecast News) - Pharmaceutical giant AstraZeneca on Monday recommended shareholders of its American depositary shares reject a $115m 'mini-tender' offer from TRC Capital Investment, due to a low bid price.
Read moreAstraZeneca reports latest positive results from Imfinzi trials
15th Oct 2021 07:49
(Sharecast News) - AstraZeneca said on Friday that positive high-level results from the 'HIMALAYA' phase 3 trial showed a single, high priming dose of tremelimumab added to 'Imfinzi', or durvalumab. demonstrated a statistically-significant and clinically meaningful overall survival (OS) benefit for carcinomas associated with liver cancer.
Read more